FDAnews
www.fdanews.com/articles/73085-anodyne-therapy-receives-regulatory-approval-from-health-canada

Anodyne Therapy Receives Regulatory Approval From Health Canada

June 7, 2005

Anodyne Therapy has announced that it has received regulatory approval from Health Canada to market its Anodyne Therapy Systems in Canada. Approved Canadian labeling, based on submission of published clinical studies, includes: temporary reduction in disturbances in skin sensation, increases in balance and reduction in fall risk (when used adjunctively with physical therapy) due to diabetic and other peripheral neuropathies. Peripheral Neuropathy is nerve damage associated with diabetes and other chronic conditions, and the symptoms include numbness and/or pain in the feet, legs and hands.

()a href="http://www.ccnmatthews.com/news/releases/show.jsp?action=showRelease&actionFor=544370" target="_blank">CCNMatthews